Anybody notified of a diagnosis of a malignant tumour is shocked due to an idea of a nearing death. However, currently many tumours can be completely treated (leucaemia , lymphoma, tumours of pathogen tissues, etc..) or at least treated with a very good prognosis for survival.

• Current therapy of malignant tumours is mostly made by applying three essential procedures.
  • Operative removal of tumour - depending on a location, type and size of the tumour.
  • „chemotherapy" - or cytostatic treatment - aimed to damage tumour cells which are more sensitive to applied drugs than other cells of an attacked organism.(somatic cells)
  • "radiotherapy" - either radiation of tumour which cannot be operated or radiation following an operation aimed to removal of potential rests of tumour cells in the surrounding of tumour.

Each of these procedures includes particular indication spectre and restrictions when it either can be used or cannot be used.

Treatment by cytostatic agents (chemotherapy) is the worst unpleasant therapy which evokes most fear. This type of therapy has many adverse side- affects, since such drugs are commonly toxic and they should frequently be applied in high doses in order to be efficient. The higher toxicity for tumour cells and the less toxicity for other somatic cells, the more suitable a drug is for therapy. Unfortunately, most current cytostatic agents seriously damages appropriate organism cells, especially newly originating cells. A significant problem related to that therapy is suppression of immune system which is responsible for organism protection against infection as well as supervision of tumour cells finding and damage. Its liquidation often results into hazardous infection complications and recurrence of cancer. That is why during the recent years many physicans consider whether the cytostatic therapy (chemotherapy) is really the best potential possibility for liquidation of malignant tumours, since its adverse impacts often prevail a general success of the therapy. Other therapeutic procedures especially aimed to support anti-tumour immunity, or efforts aimed to block enzymatic systems of tumour metabolism, starting so-called programme escape of tumour cells (apoptosis), suppression of creation of new vessels in tumour (angiogenesis, etc.) are tried.

One of side-effects of the chemotherapy, as it was already mentioned, is a damage of immune system which is not able to react efficiently potential infections. That is why it is often impossible to complete the whole planned therapy by cytostatic agents - patient is completely exhausted, weak, there is a significant risk of other infectious illnesses which consequences could be, due to the mentioned facts, tragic.

That is why it is necessary for a patient , prior to the therapy starting (especially chemotherapy) to be in a best possible physical condition. Unfortunately, especially at old people who are most often attacked by tumour illnesses, the nutrition condition is usually very bad. The efficiency of metabolism is not so good as at the youth, intestine enzymes are not produced in sufficient quantity, so that nutrition substances are worse absorbed. A content of nutrition substances in current foods is also less than, for example, forty years ago. A content of pesticides, insecticides, various fertilizers and additives block the use ability of contained vitamins and other nutrients from foods. We also know that old people do not feel hungry so often and they do not eat sufficient quantity of foods as young healthy people. However, nutrition demands are still similar, only energy value is lower with respect to a reduced physical activity of old people.

It could be stated that, with respect to lower efficiency of metabolism of old people, it needs more nutrients. Most old people are in condition of malnutrition. Tumour diseases, therefore, find such people completely not prepared and unable to face efficiently such serious disease.Our workplace makes efforts to remove such adverse factors.

• The Therapy is aimed to following objectives
  • Reduce adverse side effects of cytostatic therapy to minimum.
  • Improve the nutrition condition of a patient, his metabolism and therefore also his physical condition and performance in order to be able to pass though the whole therapy by cytostatic substances without any risk
  • Support the immune system to reduce a risk of adverse infectious complications.
  • Completing the cytostatic therapy, restore the immune system and complete health condition of a patient into an optimal condition
  • In cases when it is not possible to apply classical therapy, or when patient rejects it (which usually means chemotherapy or radiotherapy), we apply intensive immunotherapy in order to support the immune system with a complete detoxication and regeneration regime.

Detailed laboratory tests are made at patients both during the therapy and after its completion and they are monitored at our workplaces. In case of any suspicion for a tumour recidivation or occurrence of metastases, other measures are taken. The examinations are useful in order to eliminate later unpleasant surprise when a matured tumour or expanded metastases are revealed.

We have prepared a prevention programme of tumour disease occurrence for people of increased risk of cancer.